| 2020-05-20 | Sale | Charles River Laboratories International, Inc. CRL | director | 3,530 0.0071% | $174.58 | $616,263 | +34.99% | |
| 2020-02-13 | Sale | Charles River Laboratories International, Inc. CRL | director | 7,170 0.0144% | $170.41 | $1.22M | +23.92% | |
| 2019-07-31 | Bristol-Myers Squibb Company BMY | director | 22,000 0.0014% | $44.72 | $983,840 | +34.49% | ||
| 2018-12-04 | Sale | Charles River Laboratories International, Inc. CRL | director | 4,540 0.0095% | $133.99 | $608,333 | -0.37% | |
| 2018-01-02 | Sale | Charles River Laboratories International, Inc. CRL | director | 7,740 0.0161% | $109.88 | $850,502 | +3.45% | |
| 2017-03-01 | Sale | Charles River Laboratories International, Inc. CRL | director | 11,990 0.0253% | $87.80 | $1.05M | +15.95% | |
| 2003-11-17 | Merck & Co., Inc. MRK | Executive Vice President | 65,000 – | $0 | $0 | +0.83% |